region_11_23_03

East

BioScale Inc. of Boston has filed to raise $2 million through a private offering of notes. At the time of its SEC filing, the fund had already raised $1.6 million from 27 accredited investors. The developer of nanotechnology for the differentiation of chemical and biological elements plans to use the proceeds for working capital. For more information, call Mark Lundstrom, CEO, at 617-358-2650.

DAFCA Inc. of Newtonville, Mass., raised $8 million from seven accredited investors through a Series A convertible preferred participating stock round of financing. The electronic design automation software company intends to use the proceeds from the offering for working capital. For more information, call Peter Levin, CEO, at 617-630-5623.

Keel Pharmaceuticals Inc. of Cambridge, Mass., has filed to raise $3.3 million through a Series A convertible preferred stock round of financing. The company, engaged in development and commercialization of pharmaceuticals for the treatment of auto-immune diseases, intends to use the proceeds from the offering for working capital. For more information, call Richard Hoffman, president, at 617-225-0834.

ProQuent Systems Corp. of Marlborough, Mass., has filed to raise $12 million through a Series D convertible preferred stock round of financing. At the time of its SEC filing, the fund had already raised $5.2 million from eight accredited investors, $3.1 million of the amount raised accounts for conversion of bridge notes. The wireless network solutions company intends to use the proceeds from the offering for working capital. For more information, call Thomas Reid, executive officer, at 508-787-0000.

Vestmark Inc. of Wakefield, Mass., raised $196,000 from three accredited investors through a Series 3 preferred stock round of financing. The enterprise software company focused on the financial services industry intends to use the proceeds from the offering for working capital. For more information, call David Blundin, president, at 978-621-9572.

Inlet Technologies Inc. of Cary, N.C., has filed to raise $1.2 million through a Series A preferred stock round of financing. At the time of its SEC filing, the fund had already raised $159,927 from six accredited investors. The developer of technology and products related to processing of high definition media intends to use the proceeds from the offering for working capital. For more information, call Neal Page, executive officer, at 919-602-0512.

Wisair Inc. of Wilmington, Del., (the principal operations office is located in Tel Aviv, Israel) raised $15.7 million from 16 accredited investors through a private placement of Series B convertible preferred stock with warrants round of financing. The wireless technology company plans to use the proceeds for working capital. For more information, call David Yaish, CEO, at 866-809-1134.

MacroGenics Inc. of Rockville, Md., raised $5 million from one accredited investor through a Series A convertible preferred stock round of financing. The company, which is developing therapeutic antibodies for use in cancer treatment, plans to use the proceeds from the offering for working capital. For more information, call Scott Koenig, president, at 301-251-5172.

Convergent Voice Inc. of Rochester, N.Y., has filed to raise $260,000 through a private offering of common stock. At the time of its SEC filing, the fund had already raised $210,000 from three accredited investors. A minimum investment of $10,000 is required on the placement. The software developer plans to use the proceeds for salaries, fees, construction or leasing of plant buildings and facilities and working capital. For more information, call David Lanning, president, at 585-482-8060.

Altiva Corp. of Charlotte, N.C., raised $5 million from one accredited investor through a Series C convertible preferred stock round of financing. The developer of spine related medical device products intends to use the proceeds from the offering for working capital. For more information, call James Robson, president, at 704-409-1750.

Valeo Medical Inc. of Princeton, N.J., has filed to raise $750,000 through a Series A convertible preferred stock round of financing. At the time of its SEC filing, the fund had already raised $500,000 from one accredited investor. A minimum investment of $250,000 is required on the placement. The developer of medical diagnostic and therapeutic techniques and procedures intends to use the proceeds from the offering for salaries, fees as well as purchase, rental or leasing and installation of machinery and equipment. For more information, call Frederick Fritz, CEO, at 609-865-4426.

Morphotek Inc. of Exton, Pa., raised $500,000 from nine accredited investors through a private offering of convertible notes and warrants. The biotechnology company intends to use the proceeds from the offering for working capital. For more information, call Nicholas Nicolaides, president, at 610-423-6109.

Back to top


South

VocalData Inc. of Richardson, Texas, has filed to raise $10.7 million through a Series C-1 preferred stock round of financing. At the time of its SEC filing, the fund had already raised $3.9 million from three accredited investors. The provider of integrated suite of hosted IP telephony applications plans to use some proceeds from the offering for working capital. For more information, call Kim Lester, controller, at 972-354-2100.

Xenotope Diagnostics Inc. of San Antonio has filed to raise $3.1 million through a Series B preferred stock round of financing. At the time of its SEC filing, the fund had already raised $1.1 million from 16 accredited investors, approximately $873,000 of the amount raised accounts for conversion of principal and interest of promissory notes. The biotechnology company intends to use some proceeds from the offering for salaries, fees and working capital. For more information, call Paul Castella, president, at 210-582-5838.

Back to top


Midwest

iLight Technologies Inc. of Evanston, Ill., has filed to raise $4 million through a private offering of units of common stock. A minimum investment of $25,000 is required on the placement. Oakbrook Financial Group Inc. of Oakbrook, Ill., is helping to place an issue. The company, engaged in the business related to commercial lighting, intends to use the proceeds from the offering for working capital and capital expenditures. For more information, call Mark Cleaver, president, at 847-328-7800.

Algos Therapeutics Inc. of Plymouth, Minn., has filed to raise $2 million through a private offering of preferred stock. At the time of its SEC filing, the fund had already raised $1 million from 11 accredited investors. The drug discovery company focused on developing treatments for intractable pain intends to use the proceeds from the offering for salaries and fees, purchase, rental or leasing and installation of machinery and equipment, construction or leasing of plant buildings and facilities, debt repayment, research and development, and working capital. For more information, call Susanne Dvorak, CEO, at 612-306-3533.

Anulex Technologies Inc. of Plymouth, Minn., raised $13.6 million from 37 accredited investors through a Series B convertible preferred stock round of financing. The medical device company intends to use the proceeds from the offering for working capital. For more information, call Matthew Burns, CEO, at 763-551-1280.

Connected Learning Network Inc. of Louisville, Ky., has filed to raise $675,000 through a private offering of common stock. At the time of its SEC filing, the fund had already raised $590,574 from 16 accredited investors. A minimum investment of $1,000 is required on the placement. The education related company, which offers an online environment for technology assisted interactive learning, intends to use the proceeds from the offering for debt repayment and working capital. For more information, call Dean Hoke, executive officer, at 502-583-0083.

Back to top


West

Amphus Inc. of San Jose, Calif., raised $1.1 million from three accredited investors through a Series B preferred stock round of financing. A minimum investment of $200,000 was required on the placement. The developer of server architecture and server management software intends to use the proceeds from the offering for working capital. For more information, call Henry Fung, CEO, at 408-467-2100.

Aetas Technology Inc. of Irvine, Calif., has filed to raise $5 million through a private offering of debt with Series D preferred stock warrants through a bridge round of financing. At the time of its SEC filing, the fund had already raised $1 million from one accredited investor. A minimum investment of $10,000 is required on the placement. The company, which makes color fax machines, plans to use the proceeds from the offering for working capital. For more information, call David Wang, controller, at 949-737-7732.

Apptran Software Inc. of Santa Clara, Calif., raised $1.6 million from four accredited investors through a Series A preferred stock round of financing. The software server application developer intends to use the proceeds from the offering for working capital. For more information, call Duncan Greatwood, president, at 801-729-6951.

Arbios Technologies Inc. of Los Angeles raised $1.7 million from 24 accredited investors through a private offering of common stock and warrants. A minimum investment of $50,000 was required on the placement. The medical device company intends to use the proceeds from the offering for working capital. For more information, call Jacek Rozga, president, at 310-423-7702.

Array Networks Inc. of Campbell, Calif., has filed to raise $5.6 million through a Series A preferred stock round of financing. At the time of its SEC filing, the fund had already raised $3 million from one accredited investor. The developer of networking security products intends to use some proceeds from the offering for working capital. For more information, call George Chen, executive officer, at 408-378-6800.

Cenzic Inc. of Campbell, Calif., has filed to raise $7.7 million through a Series B preferred stock round of financing. At the time of its SEC filing, the fund had already raised $7.2 million from five accredited investors. The security software developer intends to use the proceeds from the offering for working capital. For more information, call John Weinschenk, president, at 408-626-9004.

Cogency Software Inc. of San Mateo, Calif., has filed to raise $7.5 million through a Series Añ1 preferred stock round of financing. At the time of its SEC filing, the fund had already raised $6 million from 12 accredited investors. The provider of network processing products and services plans to use the proceeds from the offering for working capital. For more information, call Thomas DeFilipps, executive officer, at 650-655-6700.

Covx Pharmaceuticals Inc. of San Diego raised $10.1 million from one accredited investor through a Series B preferred stock round of financing. The company, developing antibody technology, intends to use the proceeds from the offering for working capital. For more information, call Jefferson Voss, executive officer, at 858-270-5677.

DolphinSearch Inc. of Ventura, Calif., has filed to raise $3.2 million through a Series B preferred stock round of financing. At the time of its SEC filing, the fund had already raised $2.9 million from 13 accredited investors. A minimum investment of $25,000 is required on the placement. The company, developing search and retrieval systems, plans to use the proceeds for working capital and conversion of outstanding promissory notes. For more information, call Andrew Kraftsow, CEO, at 805-585-2102.

EndoMatrix Inc. of Santa Rosa, Calif., has filed to raise $3.5 million through a Series C preferred stock round of financing. At the time of its SEC filing, the fund had already raised $1.8 million from 18 accredited investors. A minimum investment of $8,000 is required on the placement. The medical device company intends to use the proceeds from the offering for working capital. For more information, call Glenn Foley, CEO, at 707-535-2990.

Entone Technologies Inc. of San Mateo, Calif., has filed to raise $17.5 million through a Series B preferred stock round of financing. At the time of its SEC filing, the company had already raised $16 million from six accredited investors. The software developer plans to use the proceeds for debt repayment and working capital. For more information, call Steve McKay, president, at 650-378-1215.

MedOptix Inc. of Cupertino, Calif., has filed to raise $1.6 million through a Series A-3 preferred stock round of financing. At the time of its SEC filing, the fund had already raised $1.5 million from 14 accredited investors. A minimum investment of $25,000 is required on the placement. The developer of blood glucose monitoring devices intends to use the proceeds from the offering for working capital. For more information, call Robert Blair, CEO, at 408-996-3500.

Method Products Inc. of San Francisco raised $3.7 million from 17 accredited investors through a Series B-1 preferred stock round of financing. The company, which designs and develops house cleaning products, plans to use the proceeds from the offering for working capital. For more information, call Alastair Dorward, CEO, at 415-931-3965.

Newport Wireless Inc. of Irvine, Calif., raised $1 million from one accredited investor through a Series D preferred stock round of financing. The developer of mobile application system for the residential real estate market plans to use the proceeds for working capital. For more information, call Ken Stockman, president, at 949-486-0785.

Sofari Inc. of San Francisco has filed to raise $850,000 through a private offering of preferred stock. At the time of its SEC filing, the fund had already raised $550,000 from two accredited investors. The publishing company plans to use the proceeds for working capital. For more information, call Christopher Alden, executive officer, at 415-922-3369.

Platform Solutions Inc. of Sunnyvale, Calif., raised $5.2 million from 16 accredited investors through a Series A preferred stock round of financing. The software developer plans to use the proceeds for working capital. For more information, call Michael Maulick, executive officer, at 408-737-3444.

SolidCore Systems Inc. of Palo Alto, Calif., has filed to raise $5.7 million through a Series A preferred stock round of financing. At the time of its SEC filing, the fund had already raised $5.4 million from five accredited investors. The software developer plans to use the proceeds for working capital. For more information, call Rosen Sharma, executive officer, at 650-566-0260.

SomaLogic Inc. of Boulder, Colo., has filed to raise $12.5 million through a Series D preferred stock round of financing. At the time of its SEC filing, the fund had already raised $5 million from one accredited investor. The life sciences company plans to use the proceeds from the offering for salaries and fees, purchase, rental or leasing and installation of machinery and equipment, construction or leasing of plant buildings and facilities, and working capital. For more information, call Scott Kothlow, executive officer, at 303-625-9000.

TransZap Inc. of Denver raised $171,960 from 10 accredited investors through a Class B-2 preferred stock round of financing. The application service provider of e-business solutions to oil and gas industry intends to use the proceeds from the offering for working capital. For more information, call Peter Flanagan, CEO, at 303-863-8600.

Back to top